Tumor‐Specific Photothermal‐Therapy‐Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles
Advanced Materials · 2023
DOI: 10.1002/adma.202300086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Tao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Shaanxi Key Laboratory of Energy Chemical Process Intensification, Institute of Polymer Science in Che…. Hauptthemen laut MEDLINE: Metal Nanoparticles, Neoplasms. Die Arbeit wurde bisher 84-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province, Opening Research Fund from Shanghai Key Laboratory of Stomatology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University, Sch….
Abstract (Originalsprache)
Multiresponsive adjuvant nanoparticles (RMmAGL) are fabricated to perform tumor‐specific photothermal therapy while regulating the behavior of tumor‐associated immune cells for primary tumor eradication and metastasis inhibition. Core–satellite‐like RMmAGL have a core of mannose‐functionalized mesoporous silica nanoparticles loaded with the TLR7 agonist imiquimod (R837@MSN‐mannose) connected via hydrazone bonds to satellites of glutamine (Glu)‐ and lysine (Lys)‐comodified gold nanoparticles (AuNPs‐Glu/Lys). During therapy, the acidic environment in tumor tissue cleaves the hydrazone bonds to release AuNPs‐Glu/Lys, which further accumulate in tumor cells. After internalization, photothermal agents (aggregated AuNPs‐Glu/Lys) are generated in situ through the intratumoral enzyme‐catalyzed reaction between Glu and Lys, resulting in tumor‐specific photothermal therapy. The detachment of AuNPs‐Glu/Lys also triggers the release of R837, which matured dendritic cells (DCs) via a vaccine‐like mechanism along with the tumor‐associated antigens generated by photothermal therapy. These matured DCs further activates surrounding T cells for immunotherapy. Moreover, the resulting free MSN‐mannose serves as an artificial glycocalyx to continuously induce the polarization of tumor‐associated macrophages from an immunosuppressive phenotype to an inflammatory phenotype, thus further enhancing immunotherapy. Both in vivo and in vitro experiments demonstrate significant inhibition of malignant tumors after therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Technology, Shaanxi Key Laboratory of Energy Chemical Process Intensification, Institute of Polymer Science in Chemical Engineering, Xi'an Jiaotong University, Xi'an, 710049, P. R. Chi…
- School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, P. R. China.
ORCID-Profile: Xin Chen
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shaanxi Province
- Opening Research Fund from Shanghai Key Laboratory of Stomatology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University, Sch…
- Shaanxi Province Science Fund for Distinguished Young Scholars
Zitieren
APA
Liu, T., Zhu, M., Chang, X., Tang, X., Yuan, P., Tian, R., Zhu, Z., Zhang, Y., & Chen, X. (2023). Tumor‐Specific Photothermal‐Therapy‐Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles. Advanced Materials. https://doi.org/10.1002/adma.202300086
Vancouver
Liu T, Zhu M, Chang X, Tang X, Yuan P, Tian R, et al. Tumor‐Specific Photothermal‐Therapy‐Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles. Advanced Materials. 2023. doi:10.1002/adma.202300086
BibTeX
@article{Liu2023,
author = {Liu, Tao and Zhu, Man and Chang, Xiaowei and Tang, Xiaoyu and Yuan, Pingyun and Tian, Ran and Zhu, Zeren and Zhang, Yanmin and Chen, Xin},
title = {Tumor‐Specific Photothermal‐Therapy‐Assisted Immunomodulation via Multiresponsive Adjuvant Nanoparticles},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202300086}
}
EUVIMED